{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:53:45Z","timestamp":1783425225451,"version":"3.54.6"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,15]]},"DOI":"10.7759\/cureus.36209","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T06:15:38Z","timestamp":1678947338000},"source":"Crossref","is-referenced-by-count":1,"title":["Effect of Ramipril on Cardiac Autonomic Neuropathy in Patients With Type II Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Chaitali A","family":"Chindhalore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh N","family":"Dakhale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathamesh H","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharatsing D","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Kumbhalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrunal S","family":"Phatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/ija.IJA_224_18","article-title":"Autonomic disturbances in diabetes: assessment and anaesthetic implications","volume":"62","author":"Moningi S","year":"2018","unstructured":"Moningi S, Nikhar S, Ramachandran G. Autonomic disturbances in diabetes: assessment and anaesthetic implications. Indian J Anaesth. 2018, 62:575-83. 10.4103\/ija.IJA_224_18","journal-title":"Indian J Anaesth"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik AI","year":"2007","unstructured":"Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007, 115:387-97. 10.1161\/CIRCULATIONAHA.106.634949","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1992.tb01898.x","article-title":"Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy","volume":"9","author":"Ziegler D","year":"1992","unstructured":"Ziegler D, Dannehl K, M\u00fchlen H, Sp\u00fcler M, Gries FA. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabet Med. 1992, 9:806-14. 10.1111\/j.1464-5491.1992.tb01898.x","journal-title":"Diabet Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.6.1895","article-title":"The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis","volume":"26","author":"Maser RE","year":"2003","unstructured":"Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003, 26:1895-901. 10.2337\/diacare.26.6.1895","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0125","article-title":"Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"33","author":"Pop-Busui R","year":"2010","unstructured":"Pop-Busui R, Evans GW, Gerstein HC, et al.. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2010, 33:1578-84. 10.2337\/dc10-0125","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-019-00693-0","article-title":"Cardiac autonomic neuropathy in obesity, the metabolic syndrome and prediabetes: a narrative review","volume":"10","author":"Williams SM","year":"2019","unstructured":"Williams SM, Eleftheriadou A, Alam U, Cuthbertson DJ, Wilding JP. Cardiac autonomic neuropathy in obesity, the metabolic syndrome and prediabetes: a narrative review. Diabetes Ther. 2019, 10:1995-2021. 10.1007\/s13300-019-00693-0","journal-title":"Diabetes Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1294","article-title":"Cardiac autonomic neuropathy in diabetes: a clinical perspective","volume":"33","author":"Pop-Busui R","year":"2010","unstructured":"Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010, 33:434-41. 10.2337\/dc09-1294","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1239","article-title":"Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management","volume":"27","author":"Spallone V","year":"2011","unstructured":"Spallone V, Ziegler D, Freeman R, et al.. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011, 27:639-53. 10.1002\/dmrr.1239","journal-title":"Diabetes Metab Res Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2013.04.007","article-title":"An approach for Ewing test selection to support the clinical assessment of cardiac autonomic neuropathy","volume":"58","author":"Stranieri A","year":"2013","unstructured":"Stranieri A, Abawajy J, Kelarev A, Huda S, Chowdhury M, Jelinek HF. An approach for Ewing test selection to support the clinical assessment of cardiac autonomic neuropathy. Artif Intell Med. 2013, 58:185-93. 10.1016\/j.artmed.2013.04.007","journal-title":"Artif Intell Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2017.41.4.275","article-title":"Effects of high-dose \u03b1-lipoic acid on heart rate variability of type 2 diabetes mellitus patients with cardiac autonomic neuropathy in Korea","volume":"41","author":"Lee SJ","year":"2017","unstructured":"Lee SJ, Jeong SJ, Lee YC, et al.. Effects of high-dose \u03b1-lipoic acid on heart rate variability of type 2 diabetes mellitus patients with cardiac autonomic neuropathy in Korea. Diabetes Metab J. 2017, 41:275-83. 10.4093\/dmj.2017.41.4.275","journal-title":"Diabetes Metab J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1510-8","article-title":"Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes","volume":"47","author":"Davies JI","year":"2004","unstructured":"Davies JI, Band M, Morris A, Struthers AD. Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes. Diabetologia. 2004, 47:1687-94. 10.1007\/s00125-004-1510-8","journal-title":"Diabetologia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman B","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, et al.. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015, 373:2117-28. 10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1580","article-title":"Effects of liraglutide on heart rate and heart rate variability: a randomized, double-blind, placebo-controlled crossover study","volume":"40","author":"Kumarathurai P","year":"2017","unstructured":"Kumarathurai P, Anholm C, Larsen BS, et al.. Effects of liraglutide on heart rate and heart rate variability: a randomized, double-blind, placebo-controlled crossover study. Diabetes Care. 2017, 40:117-24. 10.2337\/dc16-1580","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.55.02.06.db05-0885","article-title":"ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats","volume":"55","author":"Coppey LJ","year":"2006","unstructured":"Coppey LJ, Davidson EP, Rinehart TW, Gellett JS, Oltman CL, Lund DD, Yorek MA. ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes. 2006, 55:341-8. 10.2337\/diabetes.55.02.06.db05-0885","journal-title":"Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6719239","article-title":"Efficacy of administration of an angiotensin converting enzyme inhibitor for two years on autonomic and peripheral neuropathy in patients with diabetes mellitus","volume":"2017","author":"Didangelos T","year":"2017","unstructured":"Didangelos T, Tziomalos K, Margaritidis C, et al.. Efficacy of administration of an angiotensin converting enzyme inhibitor for two years on autonomic and peripheral neuropathy in patients with diabetes mellitus. J Diabetes Res. 2017, 2017:6719239. 10.1155\/2017\/6719239","journal-title":"J Diabetes Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)02478-7","article-title":"Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial","volume":"352","author":"Malik RA","year":"1998","unstructured":"Malik RA, Williamson S, Abbott C, Carrington AL, Iqbal J, Schady W, Boulton AJ. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet. 1998, 352:1978-81. 10.1016\/S0140-6736(98)02478-7","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-002-0869-7","article-title":"Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in type I diabetic patients with abnormal albuminuria","volume":"45","author":"Ebbeh\u00f8j E","year":"2002","unstructured":"Ebbeh\u00f8j E, Poulsen PL, Hansen KW, Knudsen ST, M\u00f8lgaard H, Mogensen CE. Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in type I diabetic patients with abnormal albuminuria. Diabetologia. 2002, 45:965-75. 10.1007\/s00125-002-0869-7","journal-title":"Diabetologia"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00591","article-title":"Cardiac autonomic neuropathy in diabetes: a predictor of cardiometabolic events","volume":"12","author":"Vinik AI","year":"2018","unstructured":"Vinik AI, Casellini C, Parson HK, Colberg SR, Nevoret ML. Cardiac autonomic neuropathy in diabetes: a predictor of cardiometabolic events. Front Neurosci. 2018, 12:591. 10.3389\/fnins.2018.00591","journal-title":"Front Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S129797","article-title":"Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives","volume":"10","author":"Fisher VL","year":"2017","unstructured":"Fisher VL, Tahrani AA. Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives. Diabetes Metab Syndr Obes. 2017, 10:419-34. 10.2147\/DMSO.S129797","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.285.6346.916","article-title":"Diagnosis and management of diabetic autonomic neuropathy","volume":"285","author":"Ewing DJ","year":"1982","unstructured":"Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed). 1982, 285:916-8. 10.1136\/bmj.285.6346.916","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2005.05.002","article-title":"Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy","volume":"20","author":"Didangelos TP","year":"2006","unstructured":"Didangelos TP, Arsos GA, Karamitsos DT, Athyros VG, Georga SD, Karatzas ND. Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy. J Diabetes Complications. 2006, 20:1-7. 10.1016\/j.jdiacomp.2005.05.002","journal-title":"J Diabetes Complications"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"353","author":"G\u00e6de P","year":"1999","unstructured":"G\u00e6de P, Vedel P, Parving H-H, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet. 1999, 353:617-22. 10.1016\/S0140-6736(98)07368-1","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.3.355","article-title":"Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy","volume":"20","author":"Kontopoulos AG","year":"1997","unstructured":"Kontopoulos AG, Athyros VG, Didangelos TP, Papageorgiou AA, Avramidis MJ, Mayroudi MC, Karamitsos DT. Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care. 1997, 20:355-61. 10.2337\/diacare.20.3.355","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/139881-effect-of-ramipril-on-cardiac-autonomic-neuropathy-in-patients-with-type-ii-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:49Z","timestamp":1707508549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/139881-effect-of-ramipril-on-cardiac-autonomic-neuropathy-in-patients-with-type-ii-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.36209","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,15]]}}}